248 related articles for article (PubMed ID: 2720654)
1. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
[TBL] [Abstract][Full Text] [Related]
2. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm.
Kiss R; Paridaens RJ; Heuson JC; Danguy AJ
J Natl Cancer Inst; 1986 Jul; 77(1):173-8. PubMed ID: 3459912
[TBL] [Abstract][Full Text] [Related]
3. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
Matsuzawa A; Kaneko T; Ikeda Y
Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
[TBL] [Abstract][Full Text] [Related]
4. In vivo relationship between morphonuclear parameters and hormone sensitivity of the murine MXT mammary tumor.
de Launoit Y; Kiss R
Anal Cell Pathol; 1989 Jun; 1(3):173-84. PubMed ID: 2484817
[TBL] [Abstract][Full Text] [Related]
5. Synergism or antagonism between estradiol and progesterone on the cell kinetic parameters of the MXT mouse mammary tumor.
Kiss R; Danguy AJ; Heuson JC; Paridaens RJ
J Natl Cancer Inst; 1987 Mar; 78(3):573-9. PubMed ID: 3469468
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
7. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
Yanai R; Nagasawa H
Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
[TBL] [Abstract][Full Text] [Related]
8. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm.
Kiss R; de Launoit Y; L'Hermite-Balériaux M; L'Hermite M; Paridaens RJ; Danguy AJ; Pasteels JL
J Natl Cancer Inst; 1987 May; 78(5):993-8. PubMed ID: 3472006
[TBL] [Abstract][Full Text] [Related]
10. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
11. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.
Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC
J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596
[TBL] [Abstract][Full Text] [Related]
12. [Estradiol and progesterone receptors in transplantable mouse mammary gland tumors].
Ivanova Ts; Tsingilev D; Sirakov L
Eksp Med Morfol; 1982; 21(2):95-9. PubMed ID: 7140628
[No Abstract] [Full Text] [Related]
13. Effect of estradiol -17- beta (E2) on cell proliferation in the uterus and the MXT mammary tumor borne by intact, ovariectomized and/or hypophysectomized mice.
de Launoit Y; Kiss R; Paridaens R; Danguy A; Pasteels JL
In Vivo; 1987; 1(3):173-9. PubMed ID: 2979783
[TBL] [Abstract][Full Text] [Related]
14. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors.
Moncharmont B; Ramp G; De Goeij CC; Sluyser M
Cancer Res; 1991 Aug; 51(15):3843-8. PubMed ID: 1855202
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor.
Geradts J; Richards J; Edery M; Pang K; Larson L; Nandi S
Cancer Res; 1986 Apr; 46(4 Pt 2):1920-7. PubMed ID: 3004710
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism and enzyme activities in hormone-dependent and hormone-independent mammary adenocarcinoma in GR mice.
Abraham S; Briand P; Hansen FN
J Natl Cancer Inst; 1986 Jul; 77(1):233-9. PubMed ID: 3088311
[TBL] [Abstract][Full Text] [Related]
18. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
Koseki Y; Cole D; Matsuzawa A; Costlow ME
Jpn J Cancer Res; 1987 Oct; 78(10):1105-11. PubMed ID: 3119544
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
[TBL] [Abstract][Full Text] [Related]
20. Binding of fluorescein isothiocyanate conjugated lectins to MXT mouse mammary neoplasm and their relation to steroid receptor status.
Kiss R; Lenglet G; Danguy A
Anticancer Res; 1986; 6(2):209-13. PubMed ID: 3085574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]